Quality of life as a treatment outcome in patients with cystic fibrosis
- PMID: 10212009
- DOI: 10.1592/phco.19.6.393.31047
Quality of life as a treatment outcome in patients with cystic fibrosis
Abstract
We attempted to determine the responsiveness and validity of the Quality of Well-Being (QWB) scale in 20 consecutive children and adolescents with cystic fibrosis. The QWB score was determined for 6-day periods immediately before and after hospital admission, and at 6- and 12-month follow-up. With the instrument's scale of zero-1, responsiveness was indicated by significant changes in QWB score (0.09), physical (0.019), social (0.021), and symptom-problem complexes (0.04) domains, and all pulmonary function tests from before to after treatment of an acute exacerbation. Only the symptom-problem complex domain significantly changed from after treatment to 6- and 12-month follow-up. Validity was shown by significant correlations between before and after QWB scores and forced vital capacity (r=0.476), residual volume total lung capacity ratio (r=0.452), forced expiratory volume in 1 second (r=0.358), and forced expiratory flow between 25% and 75% of vital capacity (r=0.35).
Similar articles
-
The quality of well-being in cystic fibrosis.Chest. 1989 Feb;95(2):344-7. doi: 10.1378/chest.95.2.344. Chest. 1989. PMID: 2914486
-
Non-invasive ventilation used as an adjunct to airway clearance treatments improves lung function during an acute exacerbation of cystic fibrosis: a randomised trial.J Physiother. 2015 Jul;61(3):142-7. doi: 10.1016/j.jphys.2015.05.019. Epub 2015 Jun 18. J Physiother. 2015. PMID: 26096013 Clinical Trial.
-
The Quality of Well-being Scale. Applications in AIDS, cystic fibrosis, and arthritis.Med Care. 1989 Mar;27(3 Suppl):S27-43. doi: 10.1097/00005650-198903001-00003. Med Care. 1989. PMID: 2921885
-
Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.Paediatr Drugs. 2005;7(6):353-63. doi: 10.2165/00148581-200507060-00004. Paediatr Drugs. 2005. PMID: 16356023 Review.
-
Quality of life in cystic fibrosis.J R Soc Med. 1997;90 Suppl 31(Suppl 31):37-42. doi: 10.1177/014107689709031S08. J R Soc Med. 1997. PMID: 9204010 Free PMC article. Review. No abstract available.
Cited by
-
Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients.Qual Life Res. 2003 Feb;12(1):63-76. doi: 10.1023/a:1022037320039. Qual Life Res. 2003. PMID: 12625519
-
Changes in pediatric health-related quality of life in cystic fibrosis after IV antibiotic treatment for pulmonary exacerbations.J Clin Psychol Med Settings. 2010 Mar;17(1):49-55. doi: 10.1007/s10880-009-9179-2. J Clin Psychol Med Settings. 2010. PMID: 20157799 Free PMC article.
-
The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review.Eur J Health Econ. 2023 Sep;24(7):1151-1216. doi: 10.1007/s10198-022-01541-y. Epub 2022 Nov 5. Eur J Health Econ. 2023. PMID: 36335234 Free PMC article.
-
Quality of life in children and adolescents with cystic fibrosis: implications for optimizing treatments and clinical trial design.Paediatr Drugs. 2003;5(1):41-56. doi: 10.2165/00128072-200305010-00004. Paediatr Drugs. 2003. PMID: 12513105 Review.
-
The measurement properties of tests and tools used in cystic fibrosis studies: a systematic review.Eur Respir Rev. 2021 May 11;30(160):200354. doi: 10.1183/16000617.0354-2020. Print 2021 Jun 30. Eur Respir Rev. 2021. PMID: 33980667 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical